Gerresheimer and Portal Instruments partner on needle-free drug delivery

Gerresheimer AG invested in Portal Instruments to co-develop a needle-free drug delivery platform for biologics and biosimilars, aiming to improve patient experience and expand their product portfolios.

“Together, the partners aim at transforming the administration of injectable medicines and improving the patient's experience, especially for those with chronic diseases.”prnewswire.com

• 1 source
• prnewswire.comGerresheimer and Portal enter strategic partnership to treat chronically ill patients with innovative needle-free drug-delivery solutionPortal InstrumentsMay 9, 2022

Summarized from public sources; check the original articles before acting on it.